Role of Fc receptors as a therapeutic target

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 1, 2009, Pages 80-86

  Masuda, Atsuhiro ^a,d   Yoshida, Masaru ^a   Shiomi, Hideyuki ^a   Morita, Yoshinori ^a   Kutsumi, Hiromu ^a   Inokuchi, Hideto ^a   Mizuno, Shigeto ^d   Nakamura, Akira ^b   Takai, Toshiyuki ^b   Blumberg, Richard S ^c   Azuma, Takeshi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

^d KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Fc receptors; Fc R; FcRn; IgG

Indexed keywords

CD16 ANTIGEN; ERYTHROPOIETIN; ERYTHROPOIETIN FUSION FC RECEPTOR; FC RECEPTOR; FC RECEPTOR IIB; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; NEONATAL FC RECEPTOR; UNCLASSIFIED DRUG;

ARTHRITIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BULLOUS PEMPHIGOID; CD4+ T LYMPHOCYTE; DENDRITIC CELL; DRUG MEGADOSE; DRUG PENETRATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; INFECTION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NEOPLASM; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PLASMA HALF LIFE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; DRUG THERAPY; FEEDBACK, PHYSIOLOGICAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFECTION; LYMPHOCYTE ACTIVATION; LYMPHOMA; PROTEIN TRANSPORT; RECEPTORS, FC; RECEPTORS, IGE; RECEPTORS, IGG;

EID: 70349512962     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152809787582525     Document Type: Review

References (93)

1. Ravetch, J.V.; Kinet, J.P. Fc receptors. Annu. Rev. Immunol., 1991, 9, 457-92.
2. Qiu, W.Q.; de Bruin, D.; Brownstein, B.H.; Pearse, R.; Ravetch, J.V. Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science, 1990, 248, 732-5.
3. Ravetch, J.V.; Lanier, L.L. Immune inhibitory receptors. Science, 2000, 290, 84-9.
4. Bolland, S.; Ravetch, J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity, 2000, 13, 277-85.
5. Ioan-Facsinay, A.; de Kimpe, S.J.; Hellwig, S.M.; van Lent, P.L.; Hofhuis, F.M.; van Ojik, H.H.; Sedlik, C.; da Silveira, S.A.; Gerber, J.; de Jong, Y.F.; Roozendaal, R.; Aarden, L.A.; van den Berg, W.B.; Saito, T.; Mosser, D.; Amigorena, S.; Izui, S.; van Ommen, G.J.; van Vugt, M.; van de Winkel, J.G.; Verbeek, J.S. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity, 2002, 16, 391-402.
6. Sylvestre, D.L.; Ravetch, J.V. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science, 1994, 265, 1095-8.
7. Nimmerjahn, F.; Ravetch, J.V. Fcgamma receptors: old friends and new family members. Immunity, 2006, 24, 19-28.
8. Takai, T.; Li, M.; Sylvestre, D.; Clynes, R.; Ravetch, J.V. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell, 1994, 76, 519-29.
9. Takai, T. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol., 2002, 2, 580-92.
10. Moore, T.; Ananaba, G.A.; Bolier, J.; Bowers, S.; Belay, T.; Eko, F.O.; Igietseme, J.U. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology, 2002, 105, 213-21.
11. Yoneto, T.; Waki, S.; Takai, T.; Tagawa, Y.; Iwakura, Y.; Mizuguchi, J.; Nariuchi, H.; Yoshimoto, T. A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection. J. Immunol., 2001, 166, 6236-41.
12. Onah, D.N.; Uchiyama, F.; Nagakui, Y.; Ono, M.; Takai, T.; Nawa, Y. Mucosal defense against gastrointestinal nematodes: responses of mucosal mast cells and mouse mast cell protease 1 during primary strongyloides venezuelensis infection in FcRgamma-knockout mice. Infect. Immun., 2000, 68, 4968-71.
13. Masuda, A.; Yoshida, M.; Shiomi, H.; Ikezawa, S.; Takagawa, T.; Tanaka, H.; Chinzei, R.; Ishida, T.; Morita, Y.; Kutsumi, H.; Inokuchi, H.; Wang, S.; Kobayashi, K.; Mizuno, S.; Nakamura, A.; Takai, T.; Blumberg, R.S.; Azuma, T. Fcgamma receptor regulation of Citrobacter rodentium infection. Infect. Immun., 2008, 76, 1728-37.
14. White, C.A.; Weaver, R.L.; Grillo-Lopez, A.J. Antibody-targeted immunotherapy for treatment of malignancy. Annu. Rev. Med., 2001, 52, 125-45.
15. Carter, P.J. Potent antibody therapeutics by design. Nat. Rev. Immunol., 2006, 6, 343-57.
16. Akiyama, K.; Ebihara, S.; Yada, A.; Matsumura, K.; Aiba, S.; Nukiwa, T.; Takai, T. Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells. J. Immunol., 2003, 170, 1641-8.
17. Rafiq, K.; Bergtold, A.; Clynes, R. Immune complex-mediated antigen presentation induces tumor immunity. J. Clin. Invest., 2002, 110, 71-9.
18. Clynes, R.; Takechi, Y.; Moroi, Y.; Houghton, A.; Ravetch, J.V. Fc receptors are required in passive and active immunity to melanoma. Proc. Natl. Acad. Sci. USA, 1998, 95, 652-6.
19. Bevaart, L.; Jansen, M.J.; van Vugt, M.J.; Verbeek, J.S.; van de Winkel, J.G.; Leusen, J.H. The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma. Cancer Res., 2006, 66, 1261-4.
20. Nimmerjahn, F.; Ravetch, J.V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science, 2005, 310, 1510-2.
21. Camilleri-Broet, S.; Cassard, L.; Broet, P.; Delmer, A.; Le Touneau, A.; Diebold, J.; Fridman, W.H.; Molina, T.J.; Sautes-Fridman, C. FcgammaRIIB is differentially expressed during B cell maturation and in B-cell lymphomas. Br. J. Haematol., 2004, 124, 55-62.
22. Rankin, C.T.; Veri, M.C.; Gorlatov, S.; Tuaillon, N.; Burke, S.; Huang, L.; Inzunza, H. D.; Li, H.; Thomas, S.; Johnson, S.; Stavenhagen, J.; Koenig, S.; Bonvini, E. CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma. Blood, 2006, 108, 2384-91.
23. Anderson, M.S.; Venanzi, E.S.; Klein, L.; Chen, Z.; Berzins, S.P.; Turley, S.J.; von Boehmer, H.; Bronson, R.; Dierich, A.; Benoist, C.; Mathis, D. Projection of an immunological self shadow within the thymus by the aire protein. Science, 2002, 298, 1395-401.
24. Shaheen, V.M.; Satoh, M.; Richards, H.B.; Yoshida, H.; Shaw, M.; Jennette, J.C.; Reeves, W.H. Immunopathogenesis of environmentally induced lupus in mice. Environ. Health Perspect., 1999, 107 Suppl 5, 723-7.
25. Ronnblom, L.; Pascual, V. The innate immune system in SLE: type I interferons and dendritic cells. Lupus, 2008, 17, 394-9.
26. Davies, A.J. Immunological tolerance and the autoimmune response. Autoimmun. Rev., 2008, 7, 538-43.
27. Aydar, Y.; Sukumar, S.; Szakal, A.K.; Tew, J.G. The influence of immune complex-bearing follicular dendritic cells on the IgM response, Ig class switching, and production of high affinity IgG. J. Immunol., 2005, 174, 5358-66.
28. Takai, T. Fc receptors and their role in immune regulation and autoimmunity. J. Clin. Immunol., 2005, 25, 1-18.
29. Tan Sardjono, C.; Mottram, P.L.; Hogarth, P.M. The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus. Immunol. Cell Biol., 2003, 81, 374-81.
30. Tan Sardjono, C.; Mottram, P.L.; van de Velde, N.C.; Powell, M.S.; Power, D.; Slocombe, R.F.; Wicks, I.P.; Campbell, I.K.; McKenzie, S.E.; Brooks, M.; Stevenson, A.W.; Hogarth, P.M. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Arthritis Rheum., 2005, 52, 3220-9.
31. Campbell, I.K.; Rich, M.J.; Bischof, R.J.; Hamilton, J.A. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukoc. Biol., 2000, 68, 144-50.
32. Boonyarattanakalin, S.; Martin, S.E.; Sun, Q.; Peterson, B.R. A synthetic mimic of human Fc receptors: defined chemical modification of cell surfaces enables efficient endocytic uptake of human immunoglobulin-G. J. Am. Chem. Soc., 2006, 128, 11463-70.
33. Belostocki, K.; Park, M.S.; Redecha, P.B.; Masuda, E.; Salmon, J.E.; Pricop, L. FcgammaRIIa is a target for modulation by TNFalpha in human neutrophils. Clin. Immunol., 2005, 117, 78-86.
34. Abrahamson, D.R.; Rodewald, R. Evidence for the sorting of endocytic vesicle contents during the receptor-mediated transport of IgG across the newborn rat intestine. J. Cell Biol., 1981, 91, 270-80.
35. Brambell, F.W. The transmission of immunity from mother to young and the catabolism of immunoglobulins. Lancet, 1966, 2, 1087-93.
36. Jones, E.A.; Waldmann, T.A. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J. Clin. Invest., 1972, 51, 2916-27.
37. Roberts, D.M.; Guenthert, M.; Rodewald, R. Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat. J. Cell Biol., 1990, 111, 1867-76.
38. Medesan, C.; Radu, C.; Kim, J.K.; Ghetie, V.; Ward, E.S. Localization of the site of the IgG molecule that regulates maternofetal transmission in mice. Eur. J. Immunol., 1996, 26, 2533-6.
39. Ghetie, V.; Hubbard, J.G.; Kim, J.K.; Tsen, M.F.; Lee, Y.; Ward, E.S. Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur. J. Immunol., 1996, 26, 690-6.
40. Junghans, R.P.; Anderson, C.L. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc. Natl. Acad. Sci. USA, 1996, 93, 5512-6.
41. Christianson, G.J.; Brooks, W.; Vekasi, S.; Manolfi, E.A.; Niles, J.; Roopenian, S.L.; Roths, J.B.; Rothlein, R.; Roopenian, D.C. Beta 2-microglobulin-deficient mice are protected from hypergamma-globulinemia and have defective antibody responses because of increased IgG catabolism. J. Immunol., 1997, 159, 4781-92.
42. Israel, E.J.; Wilsker, D.F.; Hayes, K.C.; Schoenfeld, D.; Simister, N.E. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology, 1996, 89, 573-8.
43. Simister, N.E.; Mostov, K.E. An Fc receptor structurally related to MHC class I antigens. Nature, 1989, 337, 184-7.
44. Burmeister, W.P.; Gastinel, L.N.; Simister, N.E.; Blum, M.L.; Bjorkman, P.J. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature, 1994, 372, 336-43.
45. Simister, N.E.; Story, C.M. Human placental Fc receptors and the transmission of antibodies from mother to fetus. J. Reprod. Immunol., 1997, 37, 1-23.
46. Ahouse, J.J.; Hagerman, C.L.; Mittal, P.; Gilbert, D.J.; Copeland, N.G.; Jenkins, N.A.; Simister, N.E. Mouse MHC class I-like Fc receptor encoded outside the MHC. J. Immunol., 1993, 151, 6076-88.
47. Story, C.M.; Mikulska, J.E.; Simister, N.E. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J. Exp. Med., 1994, 180, 2377-81.
48. Kacskovics, I.; Wu, Z.; Simister, N.E.; Frenyo, L.V.; Hammarstrom, L. Cloning and characterization of the bovine MHC class I-like Fc receptor. J. Immunol., 2000, 164, 1889-97.
49. Butler, J.E.; Sun, J.; Weber, P.; Ford, S.P.; Rehakova, Z.; Sinkora, J.; Francis, D.; Lager, K. Switch recombination in fetal porcine thymus is uncoupled from somatic mutation. Vet. Immunol. Immunopathol., 2002, 87, 307-19.
50. Mayer, B.; Zolnai, A.; Frenyo, L.V.; Jancsik, V.; Szentirmay, Z.; Hammarstrom, L.; Kacskovics, I. Redistribution of the sheep neonatal Fc receptor in the mammary gland around the time of parturition in ewes and its localization in the small intestine of neonatal lambs. Immunology, 2002, 107, 288-96.
51. Blumberg, R.S.; Koss, T.; Story, C.M.; Barisani, D.; Polischuk, J.; Lipin, A.; Pablo, L.; Green, R.; Simister, N.E. A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J. Clin. Invest., 1995, 95, 2397-402.
52. Borvak, J.; Richardson, J.; Medesan, C.; Antohe, F.; Radu, C.; Simionescu, M.; Ghetie, V.; Ward, E.S. Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int. Immunol., 1998, 10, 1289-98.
53. Cianga, P.; Medesan, C.; Richardson, J.A.; Ghetie, V.; Ward, E.S. Identification and function of neonatal Fc receptor in mammary gland of lactating mice. Eur. J. Immunol., 1999, 29, 2515-23.
54. Israel, E.J.; Taylor, S.; Wu, Z.; Mizoguchi, E.; Blumberg, R.S.; Bhan, A. Simister, N.E. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology, 1997, 92, 69-74.
55. Dickinson, B.L.; Badizadegan, K.; Wu, Z.; Ahouse, J.C.; Zhu, X.; Simister, N.E.; Blumberg, R.S.; Lencer, W.I. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J. Clin. Invest., 1999, 104, 903-11.
56. Adamski, F.M.; King, A.T.; Demmer, J. Expression of the Fc receptor in the mammary gland during lactation in the marsupial Trichosurus vulpecula (brushtail possum). Mol. Immunol., 2000, 37, 435-44.
57. Leach, J.L.; Sedmak, D.D.; Osborne, J.M.; Rahill, B.; Lairmore, M.D.; Anderson, C.L. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J. Immunol., 1996, 157, 3317-22.
58. Spiekermann, G.M.; Finn, P.W.; Ward, E.S.; Dumont, J.; Dickinson, B.L.; Blumberg, R. S.; Lencer, W.I. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J. Exp. Med., 2002, 196, 303-10.
59. Zhu, X.; Meng, G.; Dickinson, B.L.; Li, X.; Mizoguchi, E.; Miao, L.; Wang, Y.; Robert, C.; Wu, B.; Smith, P.D.; Lencer, W.I.; Blumberg, R.S. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J. Immunol., 2001, 166, 3266-76.
60. Simister, N.E.; Story, C.M.; Chen, H.L.; Hunt, J.S. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur. J. Immunol., 1996, 26, 1527-31.
61. Firan, M.; Bawdon, R.; Radu, C.; Ober, R.J.; Eaken, D.; Antohe, F.; Ghetie, V.; Ward, E. S. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int. Immunol., 2001, 13, 993-1002.
62. Dumont, J.A.; Bitonti, A.J.; Clark, D.; Evans, S.; Pickford, M.; Newman, S.P. Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway. J. Aerosol. Med., 2005, 18, 294-303.
63. Bitonti, A.J.; Dumont, J.A.; Low, S.C.; Peters, R.T.; Kropp, K.E.; Palombella, V.J.; Stattel, J.M.; Lu, Y.; Tan, C.A.; Song, J.J.; Garcia, A.M.; Simister, N.E.; Spiekermann, G.M.; Lencer, W.I.; Blumberg, R.S. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc. Natl. Acad. Sci. USA, 2004, 101, 9763-8.
64. Ghetie, V.; Ward, E.S. Transcytosis and catabolism of antibody. Immunol. Res., 2002, 25, 97-113.
65. Anderson, C.L.; Chaudhury, C.; Kim, J.; Bronson, C.L.; Wani, M.A.; Mohanty, S. Perspective - FcRn transports albumin: relevance to immunology and medicine. Trends Immunol., 2006, 27, 343-8.
66. Qiao, S.W.; Kobayashi, K.; Johansen, F.E.; Sollid, L.M.; Andersen, J.T.; Milford, E.; Roopenian, D.C.; Lencer, W.I.; Blumberg, R.S. Dependence of antibody-mediated presentation of antigen on FcRn. Proc. Natl. Acad. Sci. USA, 2008, 105, 9337-42.
67. Raghavan, M.; Bonagura, V.R.; Morrison, S.L.; Bjorkman, P.J. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry, 1995, 34, 14649-57.
68. Liu, Z.; Roopenian, D.C.; Zhou, X.; Christianson, G.J.; Diaz, L.A.; Sedmak, D.D.; Anderson, C.L. Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid. J. Exp. Med., 1997, 186, 777-83.
69. Roopenian, D.C.; Christianson, G.J.; Sproule, T.J.; Brown, A.C.; Akilesh, S.; Jung, N.; Petkova, S.; Avanessian, L.; Choi, E.Y.; Shaffer, D.J.; Eden, P.A.; Anderson, C.L. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J. Immunol., 2003, 170, 3528-33.
70. Claypool, S.M.; Dickinson, B.L.; Wagner, J.S.; Johansen, F.E.; Venu, N.; Borawski, J.A.; Lencer, W.I.; Blumberg, R.S. Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor. Mol. Biol. Cell, 2004, 15, 1746-59.
71. Ober, R.J.; Martinez, C.; Vaccaro, C.; Zhou, J.; Ward, E.S. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J. Immunol., 2004, 172, 2021-9.
72. Claypool, S.M.; Dickinson, B.L.; Yoshida, M.; Lencer, W.I.; Blumberg, R.S. Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin. J. Biol. Chem., 2002, 277, 28038-50.
73. McCarthy, K.M.; Yoong, Y.; Simister, N.E. Bidirectional transcytosis of IgG by the rat neonatal Fc receptor expressed in a rat kidney cell line: a system to study protein transport across epithelia. J. Cell Sci., 2000, 113, 1277-85.
74. Ellinger, I.; Schwab, M.; Stefanescu, A.; Hunziker, W.; Fuchs, R. IgG transport across trophoblast-derived BeWo cells: a model system to study IgG transport in the placenta. Eur. J. Immunol., 1999, 29, 733-44.
75. Yoshida, M.; Claypool, S.M.; Wagner, J.S.; Mizoguchi, E.; Mizoguchi, A.; Roopenian, D.C.; Lencer, W.I.; Blumberg, R.S. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity, 2004, 20, 769-83.
76. Mazmanian, S.K.; Liu, C.H.; Tzianabos, A.O.; Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 2005, 122, 107-18.
77. Rescigno, M.; Urbano, M.; Valzasina, B.; Francolini, M.; Rotta, G.; Bonasio, R.; Granucci, F.; Kraehenbuhl, J.P.; Ricciardi-Castagnoli, P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol., 2001, 2, 361-7.
78. Kraus, T.A.; Brimnes, J.; Muong, C.; Liu, J.H.; Moran, T.M.; Tappenden, K.A.; Boros, P.; Mayer, L. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J. Clin. Invest., 2005, 115, 2234-43.
79. Yoshida, M.; Kobayashi, K.; Kuo, T.T.; Bry, L.; Glickman, J.N.; Claypool, S.M.; Kaser, A.; Nagaishi, T.; Higgins, D.E.; Mizoguchi, E.; Wakatsuki, Y.; Roopenian, D.C.; Mizoguchi, A.; Lencer, W.I.; Blumberg, R.S. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J. Clin. Invest., 2006, 116, 2142-2151.
80. Bry, L.; Brenner, M.B. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J. Immunol., 2004, 172, 433-41.
81. Maaser, C.; Housley, M.P.; Iimura, M.; Smith, J.R.; Vallance, B.A.; Finlay, B.B.; Schreiber, J.R.; Varki, N.M.; Kagnoff, M.F.; Eckmann, L. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect. Immun., 2004, 72, 3315-24.
82. Brambell, F.W.; Hemmings, W.A.; Morris, I.G. A Theoretical Model of Gamma-Globulin Catabolism. Nature, 1964, 203, 1352-4.
83. Humphrey, J.H.; Fahey, J.L. The Metabolism of Normal Plasma Proteins and Gamma-Myeloma Protein in Mice Bearing Plasma-Cell Tumors. J. Clin. Invest., 1961, 40, 1696-705.
84. Yu, Z.; Lennon, V.A. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N. Engl. J. Med., 1999, 340, 227-8.
85. Samuelsson, A.; Towers, T.L.; Ravetch, J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science, 2001, 291, 484-6.
86. Li, N.; Zhao, M.; Hilario-Vargas, J.; Prisayanh, P.; Warren, S.; Diaz, L.A.; Roopenian, D.C.; Liu, Z. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J. Clin. Invest., 2005, 115, 3440-50.
87. Akilesh, S.; Petkova, S.; Sproule, T.J.; Shaffer, D.J.; Christianson, G.J.; Roopenian, D. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J. Clin. Invest., 2004, 113, 1328-33.
88. Raghavan, M.; Chen, M.Y.; Gastinel, L.N.; Bjorkman, P.J. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity, 1994, 1, 303-15.
89. Getman, K.E.; Balthasar, J.P. Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions. J. Pharm. Sci., 2005, 94, 718-29.
90. Liu, L.; Garcia, A.M.; Santoro, H.; Zhang, Y.; McDonnell, K.; Dumont, J.; Bitonti, A. Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade. J. Immunol., 2007, 178, 5390-8.
91. Vaccaro, C.; Zhou, J.; Ober, R.J.; Ward, E.S. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat. Biotechnol., 2005, 23, 1283-8.
92. Blumberg, R.S.; Lencer, W.I. Antibodies in the breakdown lane. Nat. Biotechnol., 2005, 23, 1232-4.
93. Mezo, A.R.; McDonnell, K.A.; Hehir, C.A.; Low, S.C.; Palombella, V.J.; Stattel, J.M.; Kamphaus, G.D.; Fraley, C.; Zhang, Y.; Dumont, J.A.; Bitonti, A.J. Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proc. Natl. Acad. Sci. USA, 2008, 105, 2337-42.